HAINAN HAIYAO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.58 CNY | +2.29% |
|
+7.51% | -20.80% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
HAINAN HAIYAO CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sale of medicines and medical instrument. The Companyâs main products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The Company distributes its products in domestic market and to overseas market, with China as its main market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -20.80% | 642M | |
| +26.47% | 664B | |
| +25.28% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +14.32% | 234B | |
| +4.74% | 199B | |
| -9.90% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- 000566 Stock
- News Hainan Haiyao Co., Ltd.
- Hainan Haiyao’s Antibiotic Passes Generic Evaluation
